Cargando…

Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal

AIM: To analyse the role of repeated breast surgery (RBS) after breast conserving surgery (BCS) as a quality indicator in a consecutive series of breast cancer patients. METHODS: Data from 1233 breast cancer patients submitted to BCS from 2015 to 2019 were reviewed. The influence of several variable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamburelli, Francesca, Maggiorotto, Furio, Marchiò, Caterina, Balmativola, Davide, Magistris, Alessandra, Kubatzki, Franziska, Sgandurra, Paola, Di Virgilio, Maria Rosaria, Regge, Daniele, Montemurro, Filippo, Gatti, Marco, Sapino, Anna, Ponzone, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451417/ https://www.ncbi.nlm.nih.gov/pubmed/32841804 http://dx.doi.org/10.1016/j.breast.2020.07.008

Ejemplares similares

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer
por: Petrelli, Annalisa, et al.
Publicado: (2020)

Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome
por: Modaffari, Paola, et al.
Publicado: (2019)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas
por: Berrino, Enrico, et al.
Publicado: (2022)

“Borderline” epithelial lesions of the breast: what have we learned in the past three decades?
por: Sapino, Anna, et al.
Publicado: (2021)

The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients
por: Castellano, Isabella, et al.
Publicado: (2017)

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients
por: Berrino, Enrico, et al.
Publicado: (2022)

Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer
por: Berrino, Enrico, et al.
Publicado: (2020)

Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem
por: Bussolati, Gianni, et al.
Publicado: (2008)

“Giants in a Microcosm”: Multinucleated Giant Cells Populating an Invasive Micropapillary Carcinoma of the Breast
por: Marchiò, Caterina, et al.
Publicado: (2015)

Breast Cancer Prevention: Can Women’s Expectations Be Met?
por: Ponzone, Riccardo
Publicado: (2016)

Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling
por: Annaratone, Laura, et al.
Publicado: (2013)

Breast cancer recurrence after reoperation for surgical bleeding
por: Pedersen, R N, et al.
Publicado: (2017)

Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes
por: Rondón-Lagos, Milena, et al.
Publicado: (2016)

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study
por: Balmativola, D., et al.
Publicado: (2014)

Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues
por: Gündisch, Sibylle, et al.
Publicado: (2015)

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
por: Ghisoni, Eleonora, et al.
Publicado: (2018)

Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues
por: Sapino, Anna, et al.
Publicado: (2013)

Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review
por: Pellegrini, Marianna, et al.
Publicado: (2023)

A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer
por: Bussolati, G, et al.
Publicado: (2005)

Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization
por: Annaratone, Laura, et al.
Publicado: (2017)

Clinical utility of exemestane in the treatment of breast cancer
por: Zucchini, Giorgia, et al.
Publicado: (2015)

Predictors of Reoperations in Deep Inferior Epigastric Perforator Flap Breast Reconstruction
por: Unukovych, Dmytro, et al.
Publicado: (2016)

Oncoplastic Surgery and the Clinical Features of Breast Cancer—Relevant Factors Associated with Reoperation in Breast Oncoplastic Surgery
por: Forma, Alicja, et al.
Publicado: (2022)

Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome
por: Metovic, Jasna, et al.
Publicado: (2022)

SF3B1 mutations constitute a novel therapeutic target in breast cancer
por: Maguire, Sarah L, et al.
Publicado: (2015)

Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study
por: Montemurro, Filippo, et al.
Publicado: (2008)

Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer
por: Pinto, António E, et al.
Publicado: (2013)

Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells
por: Rondón-Lagos, Milena, et al.
Publicado: (2014)

Underuse of Anthracyclines in Women with HER-2(+) Advanced Breast Cancer
por: Montemurro, Filippo, et al.
Publicado: (2010)

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison
por: Redana, Stefania, et al.
Publicado: (2010)

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience
por: Tuninetti, Valentina, et al.
Publicado: (2020)

Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis
por: Rondón-Lagos, Milena, et al.
Publicado: (2014)

Factors Associated with Reoperation in Breast-Conserving Surgery for Cancer: A Prospective Study of American Society of Breast Surgeon Members
por: Landercasper, Jeffrey, et al.
Publicado: (2019)

Androgen receptor status predicts development of brain metastases in ovarian cancers
por: Mittica, Gloria, et al.
Publicado: (2017)

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
por: Siravegna, Giulia, et al.
Publicado: (2017)

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment
por: Marchiò, Caterina, et al.
Publicado: (2018)

Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification
por: Ercolani, Cristiana, et al.
Publicado: (2017)

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)
por: Pisacane, Alberto, et al.
Publicado: (2022)

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)
por: Pisacane, Alberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1siglr8ni4oikg0q9e709r3785